PHILADELPHIA, PA — August 22, 2025 — Leads & Copy — Century Therapeutics, Inc. (NASDAQ: IPSC) announced that CEO Brent Pfeiffenberger will present at the H.C. Wainwright 27th Annual Global Investment Conference. Management will also hold investor meetings at the conference in New York, NY, from September 9-10, 2025.
The on-demand webcast of the presentation will be available starting at 7:00 a.m. ET on September 5, 2025, on the Investors page of Century’s website and archived for at least 30 days.
Century Therapeutics is a clinical-stage biotechnology company focused on developing cell therapies for autoimmune diseases and cancers, utilizing cellular reprogramming, genetic engineering, and manufacturing expertise.
Contact:
Douglas Carr, Senior Vice President, Finance, investor.relations@centurytx.com
Sarah McCabe, smccabe@jpa.com
